These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 3558303

  • 21. Detection of delta, core and surface antigens in the liver of chronic HBsAg carriers.
    Picciotto A, Bastardini R, Boscarino S, Lapertosa G, Mansi C, Savarino V, Celle G.
    Pathologica; 1983; 75(1035):121-5. PubMed ID: 6348677
    [No Abstract] [Full Text] [Related]

  • 22. [HBsAg in the hepatocytes in chronic liver diseases].
    Loginov AS, Aruin LI, Shepeleva SD, Tkachev VD, Zotina MM.
    Ter Arkh; 1986; 58(3):71-3. PubMed ID: 3715734
    [Abstract] [Full Text] [Related]

  • 23. Fine needle aspirative biopsy of the liver in HBsAG-positive patients with end-stage renal failure.
    Franceschini N, Goncalves LF, Prompt CA, Barros SG, Cerski CT, Costa CA.
    Ren Fail; 1994; 16(4):491-9. PubMed ID: 7938757
    [Abstract] [Full Text] [Related]

  • 24. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B.
    Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH.
    Hepatology; 1993 Dec; 18(6):1313-8. PubMed ID: 8244254
    [Abstract] [Full Text] [Related]

  • 25. Chronic delta hepatitis: a difficult problem for the hepatologist.
    Picciotto A, Celle G.
    Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
    [Abstract] [Full Text] [Related]

  • 26. Detection of hepatitis B virus in the liver by in situ hybridization (ISH) in HBsAg seropositive and seronegative patients.
    Caballero T, Caballero MA, Ruiz-Extremera A, Barrios del Pino Y, O'Valle F, Salmerón FJ, Sánchez Salgado G.
    Histol Histopathol; 1995 Apr; 10(2):265-70. PubMed ID: 7599426
    [Abstract] [Full Text] [Related]

  • 27. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R, Campbell C, Wellinghoff W, Gelb L.
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [Abstract] [Full Text] [Related]

  • 28. [Clinical significance of the appearance and dynamics of immune complexes in patients with chronic hepatitis].
    Bozić M, Milosević-Jovcić N, Cvorić M, Nikolić V, Tosić Lj.
    Srp Arh Celok Lek; 1983 Jul; 111(7):889-903. PubMed ID: 6675191
    [No Abstract] [Full Text] [Related]

  • 29. [The relationship between histologic characteristics of the liver and serologic markers in asymptomatic HBsAg carriers].
    Zhang YL.
    Zhonghua Yi Xue Za Zhi; 1983 Dec; 63(12):747-9. PubMed ID: 6426747
    [No Abstract] [Full Text] [Related]

  • 30. Relationship between HBV markers and heroin as a cause of liver injury in drug addicts.
    Vandelli C, Piaggi V, Battilani R, Cariani E, Sirotti MA.
    Drug Alcohol Depend; 1984 Oct; 14(2):129-33. PubMed ID: 6510216
    [Abstract] [Full Text] [Related]

  • 31. [Hepatitis B viral markers in the liver tissue of HBs-antigen carriers].
    Mansurov KhKh, Mirodzhov GK, Tkalicheva LI.
    Arkh Patol; 1984 Oct; 46(4):46-51. PubMed ID: 6375639
    [Abstract] [Full Text] [Related]

  • 32. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
    Radu D, Dumitraşcu D, Părău N, Urcan S, Stanciu L, Tăpălagă D, Ban A, Dumitraşcu D, Rusu C.
    Med Interne; 1984 Oct; 22(1):61-5. PubMed ID: 6710050
    [Abstract] [Full Text] [Related]

  • 33. [Morphological characteristics of the manifestation of chronic hepatitis and cirrhosis of viral etiology in chronic alcoholics].
    Shabanov AM, Domanin AA, Ivanov AA, Lubashevskiĭ VT, Shlinchak NV.
    Ter Arkh; 1987 Oct; 59(7):25-8. PubMed ID: 3672354
    [No Abstract] [Full Text] [Related]

  • 34. [Chronic hepatitis].
    Llosa R.
    Rev Gastroenterol Peru; 1989 Oct; 9(1):41-53. PubMed ID: 2490975
    [No Abstract] [Full Text] [Related]

  • 35. Laparoscopical and histological abnormalities of the liver in chronic HBs ag (hepatitis B surface antigen) carriers.
    Iwamura K.
    Tokai J Exp Clin Med; 1982 Jan; 7(1):43-51. PubMed ID: 6210975
    [Abstract] [Full Text] [Related]

  • 36. Oral pulse prednisone therapy in the treatment of HBsAg negative chronic active hepatitis.
    Chase WF, Winn RE, Mayes GR.
    Gastroenterology; 1982 Dec; 83(6):1292-6. PubMed ID: 7129032
    [Abstract] [Full Text] [Related]

  • 37. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
    Chlumská A, Stránský J, Taimr P, Baumruk L, Nevaril M.
    Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
    [Abstract] [Full Text] [Related]

  • 38. [Histochemical technics for detecting intrahepatic HBsAg by a rapid diagnosis of HBV infection].
    De Bac C, Furlan C.
    Boll Ist Sieroter Milan; 1980 Jul; 59(3):198-204. PubMed ID: 7459021
    [Abstract] [Full Text] [Related]

  • 39. Hepatocyte hepatitis B surface antigen. Diagnostic evaluation of patients with clinically acute hepatitis B surface antigen-positive hepatitis.
    Su IJ, Kuo TT, Liaw YF.
    Arch Pathol Lab Med; 1985 May; 109(5):400-2. PubMed ID: 3885902
    [Abstract] [Full Text] [Related]

  • 40. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF, Houthoff HJ, Huitema S, Wolters G, Poppema S, Gips CH.
    Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.